Back to today’s briefing

Story perspectives

Revolutionary Blood Cancer Therapy Now Available on NHS

6/13/2025

23 2

Summary

Story summary

A groundbreaking blood cancer therapy, belantamab mafodotin, is now accessible through the NHS in England. Dubbed a "Trojan horse," this treatment effectively targets myeloma cells, tripling remission durations compared to traditional options. Patients like Paul Silvester are experiencing transformative effects, reclaiming joy in their lives. Around 1,500 individuals each year stand to gain from this revolutionary approach.

1 of 1

Story summary

A groundbreaking blood cancer therapy, belantamab mafodotin, is now accessible through the NHS in England. Dubbed a "Trojan horse," this treatment effectively targets myeloma cells, tripling remission durations compared to traditional options. Patients like Paul Silvester are experiencing transformative effects, reclaiming joy in their lives. Around 1,500 individuals each year stand to gain from this revolutionary approach.